Oryzon Genomics S.A. (0RDB.L)

EUR 2.76

(-1.43%)

Eps Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual eps in 2023 was -0.06 USD , up 25.76% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly eps in 2024 Q2 was 0.00 USD , up 109.9% from previous quarter.
  • Oryzon Genomics S.A. reported an annual eps of -0.08 USD in 2022, up 18.1% from previous year.
  • Oryzon Genomics S.A. reported an annual eps of -0.10 USD in 2021, down -27.06% from previous year.
  • Oryzon Genomics S.A. reported a quarterly eps of -0.02 USD for 2024 Q1, up 38.04% from previous quarter.
  • Oryzon Genomics S.A. reported a quarterly eps of 0.02 USD for 2023 Q2, up 160.95% from previous quarter.

Annual Eps Chart of Oryzon Genomics S.A. (2023 - 2012)

Historical Annual Eps of Oryzon Genomics S.A. (2023 - 2012)

Year Eps Eps Growth
2023 -0.06 USD 25.76%
2022 -0.08 USD 18.1%
2021 -0.10 USD -27.06%
2020 -0.08 USD 13.42%
2019 -0.09 USD -158.97%
2018 -0.04 USD 81.53%
2017 -0.19 USD 9.52%
2016 -0.21 USD -435.71%
2015 -0.04 USD -113.07%
2014 0.30 USD 330.77%
2013 -0.13 USD -396.18%
2012 -0.03 USD 0.0%

Peer Eps Comparison of Oryzon Genomics S.A.

Name Eps Eps Difference
Boiron SA 2.06 EUR 102.951%
Laboratorios Farmaceuticos Rovi, S.A. 3.20 EUR 101.9%
Vetoquinol SA 4.70 EUR 101.294%
Valneva SE -0.73 EUR 91.671%
AB Science S.A. -0.20 EUR 69.6%
Nanobiotix S.A. -1.08 EUR 94.37%
PHAXIAM Therapeutics S.A. -5.00 EUR 98.784%
Vivoryon Therapeutics N.V. -1.12 EUR 94.571%
BioSenic S.A. -0.21 EUR 71.048%
ABIVAX Société Anonyme -3.43 EUR 98.227%
Formycon AG 4.76 EUR 101.277%